6-Substituted quinolines as RORγt inverse agonists.

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Structural Biology

Background:

• Retinoic acid receptor-related orphan receptor gamma t (RORγt) is a key regulator of immune responses and metabolic processes.
• RORγt activity is implicated in various autoimmune diseases and metabolic disorders, making it a significant therapeutic target.

Purpose of the Study:

• To identify and synthesize novel modulators of RORγt.
• To characterize the functional activity and binding affinity of synthesized compounds.
• To elucidate the structural basis of RORγt modulation by these novel chemical entities.

Main Methods:

• Chemical synthesis of 6-substituted quinoline derivatives.
• In vitro reporter gene assays to measure RORγt activity.
• X-ray crystallography to determine the binding mode of inverse agonists within the RORγt ligand-binding domain.

Main Results:

• Identification of 6-substituted quinolines as potent RORγt modulators.
• Optimization of substituents led to compounds with high affinity and potent inverse agonism.
• X-ray structures revealed a key interaction between the 6-position substituent and Glu379 in the RORγt ligand-binding domain.

Conclusions:

• 6-substituted quinolines represent a promising chemical class for developing RORγt-targeted therapeutics.
• The identified binding interactions provide a rational basis for further drug design and optimization.
• These findings contribute to the understanding of RORγt regulation and potential therapeutic strategies.